|
Mechanismα5β1 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with ClanoTech AB
0 Patents (Medical) associated with ClanoTech AB
100 Deals associated with ClanoTech AB
100 Translational Medicine associated with ClanoTech AB